Millennium Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.55M	Buy	519,356 +21,661	+4%	+$248K	﹤0.01%	2628
2025 Q4	$5.12M	Sell	497,695 -338,914	-41%	-$2.86M	﹤0.01%	2986
2025 Q3	$4.85M	Buy	836,609 +666,287	+391%	+$3.9M	﹤0.01%	3187
2025 Q2	$1.14M	Buy	+170,322	New	+$1.37M	﹤0.01%	4307
2025 Q1	–	Sell	-12,527	Closed	-$217K	–	6403
2024 Q4	$217K	Sell	12,527 -98,416	-89%	-$1.78M	﹤0.01%	5265
2024 Q3	$1.77M	Sell	110,943 -36,363	-25%	-$573K	﹤0.01%	3807
2024 Q2	$2.1M	Buy	147,306 +75,360	+105%	+$1.07M	﹤0.01%	3503
2024 Q1	$1.02M	Buy	71,946 +47,979	+200%	+$678K	﹤0.01%	4276
2023 Q4	$362K	Buy	+23,967	New	+$355K	﹤0.01%	4845
2023 Q3	–	Sell	-18,298	Closed	-$277K	–	6573
2023 Q2	$277K	Sell	18,298 -178,955	-91%	-$2.47M	﹤0.01%	4941
2023 Q1	$2.86M	Buy	197,253 +157,359	+394%	+$2.1M	﹤0.01%	3089
2022 Q4	$539K	Buy	+39,894	New	+$699K	﹤0.01%	4691
2022 Q3	–	Sell	-76,498	Closed	-$932K	–	7503
2022 Q2	$932K	Buy	+76,498	New	+$580K	﹤0.01%	4424
2022 Q1	–	Sell	-46,504	Closed	-$796K	–	7497
2021 Q4	$796K	Buy	+46,504	New	+$1.13M	﹤0.01%	4625